The biotech company’s pivot into digital assets marks one of the largest treasury financings to date, underscoring growing institutional demand for tokenized finance.
Just another WordPress site
			
The biotech company’s pivot into digital assets marks one of the largest treasury financings to date, underscoring growing institutional demand for tokenized finance.